Women's Health Issues
Volume 19, Issue 6 , Pages 381-389 , November 2009

Contraceptive Use and Contraception Type in Women by Body Mass Index Category

  • Amisha Schraudenbach, MPH

      Affiliations

    • University of Texas—Houston, School of Public Health, San Antonio, Texas
    • ,
  • Stephanie McFall, PhD

      Affiliations

    • Institute for Social and Economic Research, University of Essex, Colchester, United Kingdom
    • Corresponding Author InformationCorrespondence to: Stephanie McFall, PhD, Institute for Social and Economic Research, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, UK. Phone: +44 (0) 1206 873 897; fax + 44 (0) 1206 873 151.

Received 20 December 2008 ,Revised 20 May 2009 ,Accepted 6 August 2009.

References 

  1. ACOG Committee on Practice Bulletins—Gynecology. Use of hormonal contraception in women with coexisting conditions. Obstetrics & Gynecology. 2006;107:1453–1472
  2. Brunner Huber LR, Hogue CJ. The association between body weight, unintended pregnancy resulting in a live birth, and contraception at the time of conception. Maternal & Child Health Journal. 2005;9(4):413–420
  3. Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG: An International Journal of Obstetrics and Gynaecology. 2006;113(10):1126–1133
  4. Centers for Disease Control and Prevention (CDC). 2006 Behavioral Risk Factor Surveillance System overview. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006;
  5. Centers for Disease Control and Prevention (CDC). 2006 Behavioral Risk Factor Surveillance System Survey questionnaire. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006;
  6. Centers for Disease Control and Prevention (CDC), Division of Nutrition, Physical Activity and Obesity. (2008). Overweight and obesity. Available: http://www.cdc.gov/nccdphp/dnpa/obesity. Accessed April 24, 2008.
  7. Centers of Disease Control and Prevention (CDC). 2006 Behavioral Risk Factor Surveillance System Summary data quality report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2007;
  8. Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Women's Health Issues. 2005;15(4):167–173
  9. Espey E, Cosgrove E, Ogburn T. Family planning American style: Why it's so hard to control birth in the US. Obstetrics and Gynecology Clinics of North America. 2007;34(1):1
  10. Gordon, L., Thakut, N. & Atlas, M., (2007). What hormonal contraception is most effective for obese women? Available: www.jfponline.com.
  11. Grimes DA, Shields WC. Family planning for obese women: Challenges and opportunities. Contraception. 2005;72(1):1–4
  12. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents. Adults. journal of the American Medical Association. 2004;291:2847–2850
  13. Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstetrics & Gynecology. 2005;105:46–52
  14. Huber LRB, Hogue CJ, Stein AD, Drews C, Zieman M, King J, et al. Contraceptive use and discontinuation: Findings from the contraceptive history, initiation, and choice study. American Journal of Obstetrics and Gynecology. 2006;194(5):1290–1295
  15. Huber LRB, Toth JL. Obesity and oral contraceptive failure: Findings from the 2002 National Survey of Family Growth. American Journal of Epidemiology. 2007;166:1306–1311
  16. Krishnamoorthy U, Schram CMH, Hill SR. Maternal obesity in pregnancy: Is it time for meaningful research to inform preventive and management strategies?. BJOG: An International Journal of Obstetrics and Gynaecology. 2006;113(10):1134–1140
  17. Lederman SA. The effect of pregnancy weight gain on later obesity. Obstetrics & Gynecology. 1993;82:148–155
  18. Mansour D. Implications of the growing obesity epidemic on contraception and reproductive health. Journal of Family Planning & Reproductive Health Care. 2004;30(4):209–211
  19. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes and obesity related health risks. JAMA. 2003;289(1):76–79
  20. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982–2002. Advance Data. 2004;350:1–36
  21. Reece EA. Perspectives on obesity, pregnancy and birth outcomes in the United States: The scope of the problem. American Journal of Obstetrics and Gynecology. 2008;198(1):23–27
  22. Siega-Riz A, Siega-Riz A, Laraia B. The implications of maternal overweight and obesity on the course of pregnancy and birth outcomes. Maternal and Child Health Journal. 2006;10(5):S153–S156
  23. Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry. 2006;63(7):824
  24. Steiner MJ, Trussell J, Johnson S. Communicating contraceptive effectiveness: An updated counseling chart. American Journal of Obstetrics and Gynecology. 2007;197(1):118
  25. Teal SB, Ginosar DM. Contraception for women with chronic medical conditions. Obstetrics & Gynecology Clinics of North America. 2007;34(1):113–126
  26. Vahratian A. Prevalence of overweight and obesity among women of childbearing age. Maternal and Child Health Journal. 2009;13(2):268–273
  27. Vessey M. Oral contraceptive failures and body weight: Findings in a large cohort study. Journal of Family Planning and Reproductive Health Care. 2001;27:90–91
  28. Westhoff C. Higher body weight does not affect NuvaRing's efficacy. Obstetrics & Gynecology. 2005;105(Suppl.):565
  29. World Health Organization. Improving access to quality care in family planning eligibility criteria for contraceptive use. Geneva: Author; 2004;
  30. Yu CKH, Teoh TG, Robinson S. Obesity in pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology. 2006;113(10):1117–1125
  31. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertility and Sterility. 2002;77:S13–S18

PII: S1049-3867(09)00080-2

doi: 10.1016/j.whi.2009.08.002

Women's Health Issues
Volume 19, Issue 6 , Pages 381-389 , November 2009

Article Tools

* Image Usage & Resolution